Filing excerpt
For example, CMS has selected ENBREL and Otezla for Medicare price setting beginning in 2026 and 2027, respectively.
Source: Autobound Signal API · 83 signals tracked for Amgen · updated
Get Amgen's live signals in Claude or ChatGPT, or by API
What changed at Amgen this week? Use Autobound signals for amgen.com.Under the IRA, CMS implemented mandatory Medicare Part D price setting for ENBREL effective January 1, 2026, and selected Otezla for price setting beginning in 2027. These statutory pricing mandates may force Amgen to seek revenue cycle management, contract compliance, and government pricing analytics tools.
Filing excerpt
For example, CMS has selected ENBREL and Otezla for Medicare price setting beginning in 2026 and 2027, respectively.
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-10qcomplianceBurdenGet every 10-Q signal for Amgen and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Amgen this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/6b933928-19d1-4b68-8e54-43b7619e412b returns this record as JSON. POST /v1/companies/enrich returns every signal for amgen.com.
{
"signal_id": "6b933928-19d1-4b68-8e54-43b7619e412b",
"signal_type": "sec-10q",
"signal_subtype": "complianceBurden",
"detected_at": "2026-11-09T06:24:49.379+00:00",
"company": {
"name": "Amgen",
"domain": "amgen.com"
},
"data": {
"detail": "Under the IRA, CMS implemented mandatory Medicare Part D price setting for ENBREL effective January 1, 2026, and selected Otezla for price setting beginning in 2027. These statutory pricing mandates may force Amgen to seek revenue cycle management, contract compliance, and government pricing analytics tools.",
"metrics": {
"pct": -0.15,
"timeframe": "current_quarter",
"pct_context": "lower net selling price resulting from Medicare Part D price setting under the IRA"
},
"quarter": "Q1",
"summary": "CMS Implements Medicare Part D Mandatory Price Setting for ENBREL and Otezla",
"excerpts": "For example, CMS has selected ENBREL and Otezla for Medicare price setting beginning in 2026 and 2027, respectively.",
"relevance": 0.8,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/318154/000031815426000057/amgn-20260331.htm",
"filing_date": "2026-04-30",
"filing_year": 2026,
"fiscal_year": 2026,
"fiscal_year_end": "03/31",
"period_end_date": "2026-03-31",
"sales_relevance": "GRC tools needed",
"signal_category": "risk",
"regions_mentioned": [
"U.S."
]
}
}
curl https://signals.autobound.ai/v1/signals/6b933928-19d1-4b68-8e54-43b7619e412b \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"amgen.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.